0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Infectious Immunology - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-32O4001
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Infectious Immunology Market Insights and Forecast to 2028
BUY CHAPTERS

Infectious Immunology - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-32O4001
Report
September 2024
Pages:129
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Infectious Immunology - Market Size

The global market for Infectious Immunology was estimated to be worth US$ 22160 million in 2023 and is forecast to a readjusted size of US$ 37790 million by 2030 with a CAGR of 7.9% during the forecast period 2024-2030

Infectious Immunology - Market

Infectious Immunology - Market

Infection involves an attack of disease-causing agents such as bacteria and viruses on the host organism’s body that causes disturbances in normal functioning. Immunology is the study of the human body’s resistance to these infections. The combined study of infections and immunology would help authorities to handle infectious disease conditions including HIV, hepatitis, pneumonia, tuberculosis, malaria, inflammatory bowel diseases and autoimmune diseases. The infectious immunology market comprises of the diagnosis and treatment of these infectious diseases with the help of antigen antibody reactions.
The global immunology market is gaining momentum due to the availability of various drugs approved by regulatory authorities and trends of improving clinical efficacy for new drug approvals. The high prevalence of immunological disorders further drives the market. The growing number of successful clinical trials due to environmental factors and the demand for biologics leads companies to invest in developing an affordable and effective imitation of biologic drugs and biosimilars. Furthermore, the ever-increasing cases of immunological diseases worldwide due to increasing geriatric populations and the adoption of sedentary lifestyles are pushing the market for growth. Additionally, the rising research and development activities in life sciences and biologics, including immunological drugs, will support market growth. Furthermore, the growing support from the governmental bodies and the approvals from the FDA for clinical trials are expected to enhance the market revenue from the governmental bodies and the approvals from the FDA for clinical trials are expected to enhance the market revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Infectious Immunology, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Infectious Immunology by region & country, by Type, and by Application.
The Infectious Immunology market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Immunology.
Market Segmentation

Scope of Infectious Immunology - Market Report

Report Metric Details
Report Name Infectious Immunology - Market
Forecasted market size in 2030 US$ 37790 million
CAGR 7.9%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott Laboratories, Roche Diagnostics, Thermo Fisher Scientifics, Bio-Rad Laboratories, Dr. Reddy’s Laboratories, AbbVie Inc, Janssen Global Services, Johnson & Johnson, Amgen Inc, Pfizer Inc, Novartis, Astellas, Bristol-Myers Squibb Company, Merck Sharp & Dohme Corp, UCB SA, Allergan
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Infectious Immunology manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Infectious Immunology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Infectious Immunology in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Infectious Immunology - Market size in 2030?

Ans: The Infectious Immunology - Market size in 2030 will be US$ 37790 million.

Who are the main players in the Infectious Immunology - Market report?

Ans: The main players in the Infectious Immunology - Market are Abbott Laboratories, Roche Diagnostics, Thermo Fisher Scientifics, Bio-Rad Laboratories, Dr. Reddy’s Laboratories, AbbVie Inc, Janssen Global Services, Johnson & Johnson, Amgen Inc, Pfizer Inc, Novartis, Astellas, Bristol-Myers Squibb Company, Merck Sharp & Dohme Corp, UCB SA, Allergan

What are the Application segmentation covered in the Infectious Immunology - Market report?

Ans: The Applications covered in the Infectious Immunology - Market report are HIV, TB, HBV and HCV, Pneumonia, Malaria, Inflammatory Bowel Diseases, Auto Immune Diseases, Others

What are the Type segmentation covered in the Infectious Immunology - Market report?

Ans: The Types covered in the Infectious Immunology - Market report are Diagnostic Kits, Instruments, Reagents

Recommended Reports

Infectious Disease Therapeutics

Immunology & Autoimmunity

Vaccines & Prevention

1 Market Overview
1.1 Infectious Immunology Product Introduction
1.2 Global Infectious Immunology Market Size Forecast
1.3 Infectious Immunology Market Trends & Drivers
1.3.1 Infectious Immunology Industry Trends
1.3.2 Infectious Immunology Market Drivers & Opportunity
1.3.3 Infectious Immunology Market Challenges
1.3.4 Infectious Immunology Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Infectious Immunology Players Revenue Ranking (2023)
2.2 Global Infectious Immunology Revenue by Company (2019-2024)
2.3 Key Companies Infectious Immunology Manufacturing Base Distribution and Headquarters
2.4 Key Companies Infectious Immunology Product Offered
2.5 Key Companies Time to Begin Mass Production of Infectious Immunology
2.6 Infectious Immunology Market Competitive Analysis
2.6.1 Infectious Immunology Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Infectious Immunology Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Immunology as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Diagnostic Kits
3.1.2 Instruments
3.1.3 Reagents
3.2 Global Infectious Immunology Sales Value by Type
3.2.1 Global Infectious Immunology Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Infectious Immunology Sales Value, by Type (2019-2030)
3.2.3 Global Infectious Immunology Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 HIV
4.1.2 TB
4.1.3 HBV and HCV
4.1.4 Pneumonia
4.1.5 Malaria
4.1.6 Inflammatory Bowel Diseases
4.1.7 Auto Immune Diseases
4.1.8 Others
4.2 Global Infectious Immunology Sales Value by Application
4.2.1 Global Infectious Immunology Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Infectious Immunology Sales Value, by Application (2019-2030)
4.2.3 Global Infectious Immunology Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Infectious Immunology Sales Value by Region
5.1.1 Global Infectious Immunology Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Infectious Immunology Sales Value by Region (2019-2024)
5.1.3 Global Infectious Immunology Sales Value by Region (2025-2030)
5.1.4 Global Infectious Immunology Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Infectious Immunology Sales Value, 2019-2030
5.2.2 North America Infectious Immunology Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Infectious Immunology Sales Value, 2019-2030
5.3.2 Europe Infectious Immunology Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Infectious Immunology Sales Value, 2019-2030
5.4.2 Asia Pacific Infectious Immunology Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Infectious Immunology Sales Value, 2019-2030
5.5.2 South America Infectious Immunology Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Infectious Immunology Sales Value, 2019-2030
5.6.2 Middle East & Africa Infectious Immunology Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Infectious Immunology Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Infectious Immunology Sales Value
6.3 United States
6.3.1 United States Infectious Immunology Sales Value, 2019-2030
6.3.2 United States Infectious Immunology Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Infectious Immunology Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Infectious Immunology Sales Value, 2019-2030
6.4.2 Europe Infectious Immunology Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Infectious Immunology Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Infectious Immunology Sales Value, 2019-2030
6.5.2 China Infectious Immunology Sales Value by Type (%), 2023 VS 2030
6.5.3 China Infectious Immunology Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Infectious Immunology Sales Value, 2019-2030
6.6.2 Japan Infectious Immunology Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Infectious Immunology Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Infectious Immunology Sales Value, 2019-2030
6.7.2 South Korea Infectious Immunology Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Infectious Immunology Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Infectious Immunology Sales Value, 2019-2030
6.8.2 Southeast Asia Infectious Immunology Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Infectious Immunology Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Infectious Immunology Sales Value, 2019-2030
6.9.2 India Infectious Immunology Sales Value by Type (%), 2023 VS 2030
6.9.3 India Infectious Immunology Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Profile
7.1.2 Abbott Laboratories Main Business
7.1.3 Abbott Laboratories Infectious Immunology Products, Services and Solutions
7.1.4 Abbott Laboratories Infectious Immunology Revenue (US$ Million) & (2019-2024)
7.1.5 Abbott Laboratories Recent Developments
7.2 Roche Diagnostics
7.2.1 Roche Diagnostics Profile
7.2.2 Roche Diagnostics Main Business
7.2.3 Roche Diagnostics Infectious Immunology Products, Services and Solutions
7.2.4 Roche Diagnostics Infectious Immunology Revenue (US$ Million) & (2019-2024)
7.2.5 Roche Diagnostics Recent Developments
7.3 Thermo Fisher Scientifics
7.3.1 Thermo Fisher Scientifics Profile
7.3.2 Thermo Fisher Scientifics Main Business
7.3.3 Thermo Fisher Scientifics Infectious Immunology Products, Services and Solutions
7.3.4 Thermo Fisher Scientifics Infectious Immunology Revenue (US$ Million) & (2019-2024)
7.3.5 Bio-Rad Laboratories Recent Developments
7.4 Bio-Rad Laboratories
7.4.1 Bio-Rad Laboratories Profile
7.4.2 Bio-Rad Laboratories Main Business
7.4.3 Bio-Rad Laboratories Infectious Immunology Products, Services and Solutions
7.4.4 Bio-Rad Laboratories Infectious Immunology Revenue (US$ Million) & (2019-2024)
7.4.5 Bio-Rad Laboratories Recent Developments
7.5 Dr. Reddy’s Laboratories
7.5.1 Dr. Reddy’s Laboratories Profile
7.5.2 Dr. Reddy’s Laboratories Main Business
7.5.3 Dr. Reddy’s Laboratories Infectious Immunology Products, Services and Solutions
7.5.4 Dr. Reddy’s Laboratories Infectious Immunology Revenue (US$ Million) & (2019-2024)
7.5.5 Dr. Reddy’s Laboratories Recent Developments
7.6 AbbVie Inc
7.6.1 AbbVie Inc Profile
7.6.2 AbbVie Inc Main Business
7.6.3 AbbVie Inc Infectious Immunology Products, Services and Solutions
7.6.4 AbbVie Inc Infectious Immunology Revenue (US$ Million) & (2019-2024)
7.6.5 AbbVie Inc Recent Developments
7.7 Janssen Global Services
7.7.1 Janssen Global Services Profile
7.7.2 Janssen Global Services Main Business
7.7.3 Janssen Global Services Infectious Immunology Products, Services and Solutions
7.7.4 Janssen Global Services Infectious Immunology Revenue (US$ Million) & (2019-2024)
7.7.5 Janssen Global Services Recent Developments
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Profile
7.8.2 Johnson & Johnson Main Business
7.8.3 Johnson & Johnson Infectious Immunology Products, Services and Solutions
7.8.4 Johnson & Johnson Infectious Immunology Revenue (US$ Million) & (2019-2024)
7.8.5 Johnson & Johnson Recent Developments
7.9 Amgen Inc
7.9.1 Amgen Inc Profile
7.9.2 Amgen Inc Main Business
7.9.3 Amgen Inc Infectious Immunology Products, Services and Solutions
7.9.4 Amgen Inc Infectious Immunology Revenue (US$ Million) & (2019-2024)
7.9.5 Amgen Inc Recent Developments
7.10 Pfizer Inc
7.10.1 Pfizer Inc Profile
7.10.2 Pfizer Inc Main Business
7.10.3 Pfizer Inc Infectious Immunology Products, Services and Solutions
7.10.4 Pfizer Inc Infectious Immunology Revenue (US$ Million) & (2019-2024)
7.10.5 Pfizer Inc Recent Developments
7.11 Novartis
7.11.1 Novartis Profile
7.11.2 Novartis Main Business
7.11.3 Novartis Infectious Immunology Products, Services and Solutions
7.11.4 Novartis Infectious Immunology Revenue (US$ Million) & (2019-2024)
7.11.5 Novartis Recent Developments
7.12 Astellas
7.12.1 Astellas Profile
7.12.2 Astellas Main Business
7.12.3 Astellas Infectious Immunology Products, Services and Solutions
7.12.4 Astellas Infectious Immunology Revenue (US$ Million) & (2019-2024)
7.12.5 Astellas Recent Developments
7.13 Bristol-Myers Squibb Company
7.13.1 Bristol-Myers Squibb Company Profile
7.13.2 Bristol-Myers Squibb Company Main Business
7.13.3 Bristol-Myers Squibb Company Infectious Immunology Products, Services and Solutions
7.13.4 Bristol-Myers Squibb Company Infectious Immunology Revenue (US$ Million) & (2019-2024)
7.13.5 Bristol-Myers Squibb Company Recent Developments
7.14 Merck Sharp & Dohme Corp
7.14.1 Merck Sharp & Dohme Corp Profile
7.14.2 Merck Sharp & Dohme Corp Main Business
7.14.3 Merck Sharp & Dohme Corp Infectious Immunology Products, Services and Solutions
7.14.4 Merck Sharp & Dohme Corp Infectious Immunology Revenue (US$ Million) & (2019-2024)
7.14.5 Merck Sharp & Dohme Corp Recent Developments
7.15 UCB SA
7.15.1 UCB SA Profile
7.15.2 UCB SA Main Business
7.15.3 UCB SA Infectious Immunology Products, Services and Solutions
7.15.4 UCB SA Infectious Immunology Revenue (US$ Million) & (2019-2024)
7.15.5 UCB SA Recent Developments
7.16 Allergan
7.16.1 Allergan Profile
7.16.2 Allergan Main Business
7.16.3 Allergan Infectious Immunology Products, Services and Solutions
7.16.4 Allergan Infectious Immunology Revenue (US$ Million) & (2019-2024)
7.16.5 Allergan Recent Developments
8 Industry Chain Analysis
8.1 Infectious Immunology Industrial Chain
8.2 Infectious Immunology Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Infectious Immunology Sales Model
8.5.2 Sales Channel
8.5.3 Infectious Immunology Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Infectious Immunology Market Trends
    Table 2. Infectious Immunology Market Drivers & Opportunity
    Table 3. Infectious Immunology Market Challenges
    Table 4. Infectious Immunology Market Restraints
    Table 5. Global Infectious Immunology Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Infectious Immunology Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Infectious Immunology Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Infectious Immunology Product Type
    Table 9. Key Companies Time to Begin Mass Production of Infectious Immunology
    Table 10. Global Infectious Immunology Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Immunology as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Infectious Immunology Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Infectious Immunology Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Infectious Immunology Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Infectious Immunology Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Infectious Immunology Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Infectious Immunology Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Infectious Immunology Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Infectious Immunology Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Infectious Immunology Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Infectious Immunology Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Infectious Immunology Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Infectious Immunology Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Infectious Immunology Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Infectious Immunology Sales Value by Region (2019-2024) & (%)
    Table 27. Global Infectious Immunology Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Infectious Immunology Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Infectious Immunology Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Infectious Immunology Sales Value, (2025-2030) & (US$ Million)
    Table 31. Abbott Laboratories Basic Information List
    Table 32. Abbott Laboratories Description and Business Overview
    Table 33. Abbott Laboratories Infectious Immunology Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Infectious Immunology Business of Abbott Laboratories (2019-2024)
    Table 35. Abbott Laboratories Recent Developments
    Table 36. Roche Diagnostics Basic Information List
    Table 37. Roche Diagnostics Description and Business Overview
    Table 38. Roche Diagnostics Infectious Immunology Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Infectious Immunology Business of Roche Diagnostics (2019-2024)
    Table 40. Roche Diagnostics Recent Developments
    Table 41. Thermo Fisher Scientifics Basic Information List
    Table 42. Thermo Fisher Scientifics Description and Business Overview
    Table 43. Thermo Fisher Scientifics Infectious Immunology Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Infectious Immunology Business of Thermo Fisher Scientifics (2019-2024)
    Table 45. Thermo Fisher Scientifics Recent Developments
    Table 46. Bio-Rad Laboratories Basic Information List
    Table 47. Bio-Rad Laboratories Description and Business Overview
    Table 48. Bio-Rad Laboratories Infectious Immunology Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Infectious Immunology Business of Bio-Rad Laboratories (2019-2024)
    Table 50. Bio-Rad Laboratories Recent Developments
    Table 51. Dr. Reddy’s Laboratories Basic Information List
    Table 52. Dr. Reddy’s Laboratories Description and Business Overview
    Table 53. Dr. Reddy’s Laboratories Infectious Immunology Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Infectious Immunology Business of Dr. Reddy’s Laboratories (2019-2024)
    Table 55. Dr. Reddy’s Laboratories Recent Developments
    Table 56. AbbVie Inc Basic Information List
    Table 57. AbbVie Inc Description and Business Overview
    Table 58. AbbVie Inc Infectious Immunology Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Infectious Immunology Business of AbbVie Inc (2019-2024)
    Table 60. AbbVie Inc Recent Developments
    Table 61. Janssen Global Services Basic Information List
    Table 62. Janssen Global Services Description and Business Overview
    Table 63. Janssen Global Services Infectious Immunology Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Infectious Immunology Business of Janssen Global Services (2019-2024)
    Table 65. Janssen Global Services Recent Developments
    Table 66. Johnson & Johnson Basic Information List
    Table 67. Johnson & Johnson Description and Business Overview
    Table 68. Johnson & Johnson Infectious Immunology Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Infectious Immunology Business of Johnson & Johnson (2019-2024)
    Table 70. Johnson & Johnson Recent Developments
    Table 71. Amgen Inc Basic Information List
    Table 72. Amgen Inc Description and Business Overview
    Table 73. Amgen Inc Infectious Immunology Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Infectious Immunology Business of Amgen Inc (2019-2024)
    Table 75. Amgen Inc Recent Developments
    Table 76. Pfizer Inc Basic Information List
    Table 77. Pfizer Inc Description and Business Overview
    Table 78. Pfizer Inc Infectious Immunology Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Infectious Immunology Business of Pfizer Inc (2019-2024)
    Table 80. Pfizer Inc Recent Developments
    Table 81. Novartis Basic Information List
    Table 82. Novartis Description and Business Overview
    Table 83. Novartis Infectious Immunology Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Infectious Immunology Business of Novartis (2019-2024)
    Table 85. Novartis Recent Developments
    Table 86. Astellas Basic Information List
    Table 87. Astellas Description and Business Overview
    Table 88. Astellas Infectious Immunology Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Infectious Immunology Business of Astellas (2019-2024)
    Table 90. Astellas Recent Developments
    Table 91. Bristol-Myers Squibb Company Basic Information List
    Table 92. Bristol-Myers Squibb Company Description and Business Overview
    Table 93. Bristol-Myers Squibb Company Infectious Immunology Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Infectious Immunology Business of Bristol-Myers Squibb Company (2019-2024)
    Table 95. Bristol-Myers Squibb Company Recent Developments
    Table 96. Merck Sharp & Dohme Corp Basic Information List
    Table 97. Merck Sharp & Dohme Corp Description and Business Overview
    Table 98. Merck Sharp & Dohme Corp Infectious Immunology Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Infectious Immunology Business of Merck Sharp & Dohme Corp (2019-2024)
    Table 100. Merck Sharp & Dohme Corp Recent Developments
    Table 101. UCB SA Basic Information List
    Table 102. UCB SA Description and Business Overview
    Table 103. UCB SA Infectious Immunology Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Infectious Immunology Business of UCB SA (2019-2024)
    Table 105. UCB SA Recent Developments
    Table 106. Allergan Basic Information List
    Table 107. Allergan Description and Business Overview
    Table 108. Allergan Infectious Immunology Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Infectious Immunology Business of Allergan (2019-2024)
    Table 110. Allergan Recent Developments
    Table 111. Key Raw Materials Lists
    Table 112. Raw Materials Key Suppliers Lists
    Table 113. Infectious Immunology Downstream Customers
    Table 114. Infectious Immunology Distributors List
    Table 115. Research Programs/Design for This Report
    Table 116. Key Data Information from Secondary Sources
    Table 117. Key Data Information from Primary Sources
    Table 118. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Infectious Immunology Product Picture
    Figure 2. Global Infectious Immunology Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Infectious Immunology Sales Value (2019-2030) & (US$ Million)
    Figure 4. Infectious Immunology Report Years Considered
    Figure 5. Global Infectious Immunology Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Infectious Immunology Revenue in 2023
    Figure 7. Infectious Immunology Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Diagnostic Kits Picture
    Figure 9. Instruments Picture
    Figure 10. Reagents Picture
    Figure 11. Global Infectious Immunology Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global Infectious Immunology Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of HIV
    Figure 14. Product Picture of TB
    Figure 15. Product Picture of HBV and HCV
    Figure 16. Product Picture of Pneumonia
    Figure 17. Product Picture of Malaria
    Figure 18. Product Picture of Inflammatory Bowel Diseases
    Figure 19. Product Picture of Auto Immune Diseases
    Figure 20. Product Picture of Others
    Figure 21. Global Infectious Immunology Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Infectious Immunology Sales Value Market Share by Application, 2023 & 2030
    Figure 23. North America Infectious Immunology Sales Value (2019-2030) & (US$ Million)
    Figure 24. North America Infectious Immunology Sales Value by Country (%), 2023 VS 2030
    Figure 25. Europe Infectious Immunology Sales Value (2019-2030) & (US$ Million)
    Figure 26. Europe Infectious Immunology Sales Value by Country (%), 2023 VS 2030
    Figure 27. Asia Pacific Infectious Immunology Sales Value (2019-2030) & (US$ Million)
    Figure 28. Asia Pacific Infectious Immunology Sales Value by Country (%), 2023 VS 2030
    Figure 29. South America Infectious Immunology Sales Value (2019-2030) & (US$ Million)
    Figure 30. South America Infectious Immunology Sales Value by Country (%), 2023 VS 2030
    Figure 31. Middle East & Africa Infectious Immunology Sales Value (2019-2030) & (US$ Million)
    Figure 32. Middle East & Africa Infectious Immunology Sales Value by Country (%), 2023 VS 2030
    Figure 33. Key Countries/Regions Infectious Immunology Sales Value (%), (2019-2030)
    Figure 34. United States Infectious Immunology Sales Value, (2019-2030) & (US$ Million)
    Figure 35. United States Infectious Immunology Sales Value by Type (%), 2023 VS 2030
    Figure 36. United States Infectious Immunology Sales Value by Application (%), 2023 VS 2030
    Figure 37. Europe Infectious Immunology Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Europe Infectious Immunology Sales Value by Type (%), 2023 VS 2030
    Figure 39. Europe Infectious Immunology Sales Value by Application (%), 2023 VS 2030
    Figure 40. China Infectious Immunology Sales Value, (2019-2030) & (US$ Million)
    Figure 41. China Infectious Immunology Sales Value by Type (%), 2023 VS 2030
    Figure 42. China Infectious Immunology Sales Value by Application (%), 2023 VS 2030
    Figure 43. Japan Infectious Immunology Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Japan Infectious Immunology Sales Value by Type (%), 2023 VS 2030
    Figure 45. Japan Infectious Immunology Sales Value by Application (%), 2023 VS 2030
    Figure 46. South Korea Infectious Immunology Sales Value, (2019-2030) & (US$ Million)
    Figure 47. South Korea Infectious Immunology Sales Value by Type (%), 2023 VS 2030
    Figure 48. South Korea Infectious Immunology Sales Value by Application (%), 2023 VS 2030
    Figure 49. Southeast Asia Infectious Immunology Sales Value, (2019-2030) & (US$ Million)
    Figure 50. Southeast Asia Infectious Immunology Sales Value by Type (%), 2023 VS 2030
    Figure 51. Southeast Asia Infectious Immunology Sales Value by Application (%), 2023 VS 2030
    Figure 52. India Infectious Immunology Sales Value, (2019-2030) & (US$ Million)
    Figure 53. India Infectious Immunology Sales Value by Type (%), 2023 VS 2030
    Figure 54. India Infectious Immunology Sales Value by Application (%), 2023 VS 2030
    Figure 55. Infectious Immunology Industrial Chain
    Figure 56. Infectious Immunology Manufacturing Cost Structure
    Figure 57. Channels of Distribution (Direct Sales, and Distribution)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS